Leuprorelin Prostap

Leuprorelin Prostap

This chemotherapy and cancer drugs article is about Leuprorelin (Prostap) which is used in the treatment of prostate cancer. It is a hormone therapy that lowers the level of testosterone in the body.  It does this by reducing the production of luteinising hormone produced in the pituitary gland which then acts on testosterone production.  It can be used as a sole treatment for advanced prostrate cancer or for older men not wishing to have surgery or radiotherapy.

Side effects can include: hot flushes, mood swings, impotence, breast tenderness, fatigue, weight gain, pain in muscles and joints, nausea, vomiting and mild diarrhoea.
There is a long-term risk of osteoporosis. Generally side effects are minimal.

Approved by

the Medical Board. 

Click Here







Other articles that you may find interesting are:

  1. A diet for Chemotherapy
  2. Immunotherapy overview
  3. A to Z Guide to Complementary Therapies

Go to: Return to the CANCERactive drug list



Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our

Join Our Newsletter Signup today for free and be the first to get notified on new updates.